IDO-competent-DCs induced by IFN-γ attenuate acute rejection in rat liver transplantation

Journal of Clinical Immunology

Volumn 32, Issue 4, 2012, Pages 837-847

  Sun, Xing ^a   Gong, Zi Jun ^a   Wang, Zhao Wen ^a   Li, Tao ^a   Zhang, Jin Yan ^a   Sun, Hong Cheng ^a   Liu, Shuang ^a   Huang, Li ^a   Huang, Chen ^a   Peng, Zhi Hai ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Acute rejection; Apoptosis; Dendritic cell; Immune tolerance; Indoleamine 2,3 dioxygenase; Liver transplantation

Indexed keywords

GAMMA INTERFERON; INDOLEAMINE 2,3 DIOXYGENASE;

ACUTE GRAFT REJECTION; ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DENDRITIC CELL; DISEASE SEVERITY; ENZYME ACTIVITY; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IDO GENE; IMMUNOLOGICAL TOLERANCE; ISOGRAFT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MALE; MICRODIALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPRAGUE DAWLEY RAT; SURVIVAL RATE; SURVIVAL TIME; TRYPTOPHAN METABOLISM; UPREGULATION; WISTAR RAT;

ANIMALS; DENDRITIC CELLS; GRAFT REJECTION; IMMUNE TOLERANCE; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERFERON-GAMMA; LIVER; LIVER TRANSPLANTATION; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; TRANSPLANTATION, HOMOLOGOUS; TRYPTOPHAN;

EID: 84863989976     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-012-9681-4     Document Type: Article

References (26)

1. Starzl TE, Marchioro TL, Vonkaulla KN, Hermann G, Brittain RS, Waddell WR. Homotransplantation of the liver in humans. Surg Gynecol Obstet. 1963;117:659-76.
2. Seetharam A, Tiriveedhi V, Mohanakumar T. Alloimmunity and autoimmunity in chronic rejection. Curr Opin Organ Transplant. 2010;15(4):531-6. doi:10.1097/MOT.0b013e32833b31f4.
3. Lombardi G, Sagoo P, Scotta C, Fazekasova H, Smyth L, Tsang J, et al. Cell therapy to promote transplantation tolerance: A winning strategy? Immunotherapy. 2011;3(4 Suppl):28-31. doi:10.2217/imt.11.42.
4. Dresske B, Lin X, Huang DS, Zhou X, Fandrich F. Spontaneous tolerance: Experience with the rat liver transplant model. Hum Immunol. 2002;63(10):853-61. (Pubitemid 35246765)
5. Blaha P, Bigenzahn S, Koporc Z, Sykes M, Muehlbacher F,Wekerle T. Short-term immunosuppression facilitates induction of mixed chimerism and tolerance after bone marrow transplantation without cytoreductive conditioning. Transplantation. 2005;80(2):237-43. (Pubitemid 41061681)
6. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299(5609):1057-61. doi:10.1126/science.1079490. (Pubitemid 36222930)
7. Taflin C, Nochy D, Hill G, Frouget T, Rioux N, Verine J, et al. Regulatory T cells in kidney allograft infiltrates correlate with initial inflammation and graft function. Transplantation. 2010;89 (2):194-9. doi:10.1097/TP.0b013e3181c3ca11.
8. Wei S, Li J, Lian Z, Chen Y, Liu Z, You H, et al. Expression of glucocorticoid-induced tumor necrosis factor receptor ligand in rat graft after liver transplantation. Transplant Proc. 2011;43(5):1971- 5. doi:10.1016/j. transproceed.2011.03.054.
9. Huang YL, Wang YZ, Chen JB, Wang F, Kang XP, Xia JJ, et al. Prevention of acute and chronic allograft rejection by combinations of tolerogenic dendritic cells. Scand J Immunol. 2011;73 (2):91-101. doi:10.1111/j.1365-3083.2010.02485. x.
10. van Kooten C, Lombardi G, Gelderman KA, Sagoo P, Buckland M, Lechler R, et al. Dendritic cells as a tool to induce transplantation tolerance: obstacles and opportunities. Transplantation. 2011;91(1):2-7.
11. Ezzelarab M, Thomson AW. Tolerogenic dendritic cells and their role in transplantation. Semin Immunol. 2011. doi:10.1016/j.smim.2011.06.007.
12. Natarajan S, Thomson AW. Tolerogenic dendritic cells and myeloid-derived suppressor cells: Potential for regulation and therapy of liver auto- and alloimmunity. Immunobiology. 2010;215(9-10):698-703. doi:10.1016/j.imbio.2010. 05.024.
13. Li J, Meinhardt A, Roehrich ME, Golshayan D, Dudler J, Pagnotta M, et al. Indoleamine 2,3-dioxygenase gene transfer prolongs cardiac allograft survival. Am J Physiol Heart Circ Physiol. 2007;293(6):H3415-23. doi:10.1152/ajpheart. 00532.2007. (Pubitemid 350230883)
14. Laurence JM, Wang C, Zheng M, Cunningham S, Earl J, Tay SS, et al. Overexpression of indoleamine dioxygenase in rat liver allografts using a high-efficiency adeno-associated virus vector does not prevent acute rejection. Liver Transpl. 2009;15(2):233-41. doi:10.1002/lt.21662.
15. Medzhitov R, Shevach EM, Trinchieri G, Mellor AL, Munn DH, Gordon S, et al. Highlights of 10 years of immunology in Nature Reviews Immunology. Nat Rev Immunol. 2011;11(10):693-702. doi:10.1038/nri3063
16. Terness P, Chuang JJ, Bauer T, Jiga L, Opelz G. Regulation of human auto- and alloreactive T cells by indoleamine 2,3-dioxygenase (IDO)-producing dendritic cells: Too much ado about IDO? Blood. 2005;105(6):2480-6. doi:10.1182/blood-2004-06-2103. (Pubitemid 40387049)
17. Shumakov VI, Moisiuk Ia G, Shagidulin M. [The evolution of surgical techniques for donor liver procurement]. Vestn Ross Akad Med Nauk. 2006(12):7-11.
18. Cannazza G, Baraldi M, Braghiroli D, Tait A, Parenti C. Highperformance liquid chromatographic method for the quantification of anthranilic and 3-hydroxyanthranilic acid in rat brain dialysate. J Pharm Biomed Anal. 2003;32(2):287-93. (Pubitemid 36588729)
19. Banff schema for grading liver allograft rejection: An international consensus document. Hepatology. 1997;25:6.
20. Yu G, Fang M, Gong M, Liu L, Zhong J, Feng W, et al. Steady state dendritic cells with forced IDO expression induce skin allograft tolerance by upregulation of regulatory T cells. Transpl Immunol. 2008;18(3):208-19. doi:10.1016/j.trim.2007.08.006. (Pubitemid 350151858)
21. Ingelsten M, Gustafsson K, Oltean M, Karlsson-Parra A, Olausson M, Haraldsson B, et al. Is indoleamine 2,3-dioxygenase important for graft acceptance in highly sensitized patients after combined auxiliary liver-kidney transplantation? Transplantation. 2009;88 (7):911-9. doi:10.1097/TP. 0b013e3181b72e49.
22. Terness P, Bauer TM, Rose L, Dufter C, Watzlik A, Simon H, et al. Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: Mediation of suppression by tryptophan metabolites. J Exp Med. 2002;196 (4):447-57.
23. Ge W, Jiang J, Arp J, Liu W, Garcia B, Wang H. Regulatory T-cell generation and kidney allograft tolerance induced by mesenchymal stem cells associated with indoleamine 2,3-dioxygenase expression. Transplantation. 2010;90(12):1312-20. doi:10.1097/TP.0b013e3181fed001.
24. Palafox D, Llorente L, Alberu J, Torres-Machorro A, Camorlinga N, Rodriguez C, et al. The role of indoleamine 2,3 dioxygenase in the induction of immune tolerance in organ transplantation. Transplant Rev (Orlando). 2010;24(3):160-5. doi:10.1016/j.trre.2010.04.003.
25. Ghahary A, Li Y, Tredget EE, Kilani RT, Iwashina T, Karami A, et al. Expression of indoleamine 2,3-dioxygenase in dermal fibroblasts functions as a local immunosuppressive factor. J Invest Dermatol . 2004;122(4):953-64. doi:10.1111/j .0022- 202X.2004.22409.x. (Pubitemid 38580998)
26. Munn DH, Sharma MD, Lee JR, Jhaver KG, Johnson TS, Keskin DB, et al. Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science. 2002;297 (5588):1867-70. doi:10.1126/science.1073514. (Pubitemid 35024345)